AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7043162
Drug: 5 or
RxNorm normalized name: Acys-5 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 or 10 g GABA (intervention)
Trial: 7043162
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg muscimol (intervention)
Trial: 25091663
Drug: 116E rotavirus
RxNorm normalized name: ROTAVIRUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 116E rotavirus vaccine
Trial: 17317370
Drug: Rosuvastatin 40
RxNorm normalized name: rosuvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 40 mg + Ezetimibe 10 mg
Trial: 11274548
Drug: Triple-dose gadodiamide
RxNorm normalized name: Gadodiamide
DrugBank: Gadodiamide (DB00225)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triple-dose gadodiamide (0.3 mmol/kg)
Trial: 11274548
Drug: Single-dose gadodiamide
RxNorm normalized name: Gadodiamide
DrugBank: Gadodiamide (DB00225)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose gadodiamide (0.1 mmol/kg)
Trial: 9737831
Drug: Azelaic acid
RxNorm normalized name: Azelaic Acid
DrugBank: Azelaic acid (DB00548)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Azelaic acid 20% cream and glycolic acid lotion
Trial: 7913292
Drug: eformoterol 24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eformoterol 24 micrograms twice daily
Trial: 21144515
Drug: Intravenous nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nitroglycerin (200 μg)
Trial: 18295465
Drug: Immediate release
RxNorm normalized name: Namenda, immediate release oral kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate release Ikorel tablet
Trial: 16863527
Drug: Zinc sulfate
RxNorm normalized name: Zinc Sulfate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc sulfate 100 mg three times per day
Trial: 12645862
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg lignocaine
Trial: 12645862
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg lignocaine
Trial: 11289670
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A supplementation (200,000 IU, 2 doses at baseline, additional doses at 4 and 8 months)
Trial: 9316621
Drug: rhIL-1 beta
RxNorm normalized name: interleukin-1, beta
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhIL-1 beta (all dose levels)
Trial: 8451780
Drug: Chloroquine (CQ)
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine (CQ) 300 mg
Trial: 3092053
Drug: Diazepam (tapered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (tapered doses)
Trial: 30830119
Drug: Choline alfoscerate
RxNorm normalized name: Choline Alfoscerate
DrugBank: Choline alfoscerate (DB04660)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choline alfoscerate (ChA) 14 mg/kg
Trial: 30830119
Drug: Succinate combination
RxNorm normalized name: succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Succinate combination (SC) 0.5 mg/kg
Trial: 30830119
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ChA and SC
Trial: 27062963
Drug: Decaffeinated green
RxNorm normalized name: (-)-EPIGALLOCATECHIN-3-O-GALLATE (EGCG) (CONSTITUENT OF POWDERED DECAFFEINATED GREEN TEA EXTRACT) [DSC]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decaffeinated green tea extract (GTE) 1500 mg daily for 4 weeks
Trial: 23200974
Drug: Topical 2%
RxNorm normalized name: menthol topical 2% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 2% lignocaine jelly
Trial: 20739853
Drug: Good glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Good glucose control (target glucose level of 130 mg/dL)
Trial: 20739853
Drug: Poor glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Poor glucose control (glucose levels above 130 mg/dL)
Trial: 28438257
Drug: Test allopurinol
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Test allopurinol tablet (300 mg)
Trial: 28438257
Drug: Reference allopurinol
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reference allopurinol tablet (300 mg)
Trial: 8840352
Drug: Arecoline 1
RxNorm normalized name: bethanechol chloride Injectable Solution [Urecholine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arecoline 1 mg/day
Trial: 8840352
Drug: Arecoline 4
RxNorm normalized name: bethanechol chloride Injectable Solution [Urecholine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arecoline 4 mg/day
Trial: 8840352
Drug: Arecoline 16
RxNorm normalized name: bethanechol chloride Injectable Solution [Urecholine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arecoline 16 mg/day
Trial: 8840352
Drug: Arecoline 28
RxNorm normalized name: bethanechol chloride Injectable Solution [Urecholine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arecoline 28 mg/day
Trial: 8840352
Drug: Arecoline 40
RxNorm normalized name: bethanechol chloride Injectable Solution [Urecholine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arecoline 40 mg/day
Trial: 1751666
Drug: Fibrous carbon
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fibrous carbon enterosorbent VESTA in tablets for 14 days (group I)
Trial: 1751666
Drug: Parenteral administration
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral administration of hemostimulants, hemosubstitutes and detoxicants (group II)
Trial: 6818596
Drug: Chlorpromazine (CPZ)
RxNorm normalized name: Chlorpromazine
DrugBank: Chlorpromazine (DB00477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (CPZ) 12.5 mg
Trial: 6818596
Drug: Chlorpromazine (CPZ)
RxNorm normalized name: Chlorpromazine
DrugBank: Chlorpromazine (DB00477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (CPZ) 25.0 mg
Trial: 15813835
Drug: Capsules taken
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsules taken just before meals (schedule A)
Trial: 15813835
Drug: Capsules taken
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsules taken just after meals (schedule B)
Trial: 15813835
Drug: Capsules taken
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsules taken along with meals (schedule C)
Trial: 12748463
Drug: EE/levonorgestrel (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EE/levonorgestrel (0.3 mg ethinyl estradiol / 0.15 mg levonorgestrel)
Trial: 12748463
Drug: EE/desogestrel (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EE/desogestrel (0.3 mg ethinyl estradiol / 0.15 mg desogestrel)
Trial: 8792107
Drug: Pooled Micral-Test
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pooled Micral-Test result (> or = 15 mg/l)
Trial: 1352370
Drug: RU 42
RxNorm normalized name: RUS 3108
DrugBank: RUS 3108 (DB05911)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RU 42 173 (0.25 mg single oral dose)
Trial: 6397914
Drug: Herbal combination
RxNorm normalized name: HERBAL MISCELLANEOUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal combination Dietosan (species)
Trial: 6397914
Drug: Herbal combination
RxNorm normalized name: HERBAL MISCELLANEOUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal combination Dietosan (disperg)
Trial: 6397914
Drug: Herbal combination
RxNorm normalized name: HERBAL MISCELLANEOUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal combination Dietosan (species) with glybenclamide
Trial: 6397914
Drug: Herbal combination
RxNorm normalized name: HERBAL MISCELLANEOUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal combination Dietosan (disperg) with glybenclamide
Trial: 6397914
Drug: Herbal combination
RxNorm normalized name: HERBAL MISCELLANEOUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal combination Dietosan (species and disperg)
Trial: 30964820
Drug: Oropharyngeal colostrum
RxNorm normalized name: COLOSTRUM
DrugBank: Human colostrum (DB19286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oropharyngeal colostrum administration (0.2 mL every 2 hours for 48 hours)
Trial: 30964820
Drug: Placebo (sterile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (sterile water, 0.2 mL every 2 hours for 48 hours)
Trial: 30964820
Drug: Oropharyngeal colostrum
RxNorm normalized name: COLOSTRUM
DrugBank: Human colostrum (DB19286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oropharyngeal colostrum administration
Trial: 27223302
Drug: Dark chocolate
RxNorm normalized name: Ensure Original Dark Chocolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dark chocolate (65 g)
Trial: 27223302
Drug: Yerba mate
RxNorm normalized name: yerba mate
DrugBank: Ilex paraguariensis leaf (DB14366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yerba mate (3 g)
Trial: 22424011
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of loop diuretics and spironolactone use
Trial: 22424011
Drug: Angiotensin‐converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin‐converting enzyme inhibitor, angiotensin receptor blocker, and β‐blocker use
Trial: 31116848
Drug: Conservative Medical
RxNorm normalized name: Conserved dopamine neurotrophic factor
DrugBank: HER-902 (DB17948)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative Medical Therapy (CMT)
Trial: 10989854
Drug: 4 microg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 microg/kg remifentanil and 3.5 mg/kg propofol
Trial: 9192229
Drug: Education through
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Education through monthly newsletters and semiannual classes on nutrition and exercise
Trial: 1311666
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium metered dose aerosol 4 mg twice daily
Trial: 3923726
Drug: prazosin 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: prazosin 20 mg/d orally (n = 12)
Trial: 30572270
Drug: Pea fiber
RxNorm normalized name: Pea fiber
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pea fiber (PF, 15 g/d in wafer form; n=29)
Trial: 16632811
Drug: Acetaminophen 60
RxNorm normalized name: acetaminophen 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 60 mg/kg rectally and 40 mg/kg orally
Trial: 16632811
Drug: Ketoprofen 2
RxNorm normalized name: ketoprofen 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 2 mg/kg IV twice
Trial: 16632811
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of acetaminophen and ketoprofen
Trial: 10780130
Drug: Universal preventive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Universal preventive intervention for conduct disorder; specific dosage and duration not mentioned.
Trial: 8737186
Drug: Dopamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine infusion (0.01 microgram/kg/min)
Trial: 8737186
Drug: Metoclopramide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide (10 mg as i.v. bolus)
Trial: 8737186
Drug: Dopamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine infusion followed by metoclopramide (10 mg bolus after 2 hours)
Trial: 8737186
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion (4-hour)
Trial: 29604894
Drug: Global ground-state
RxNorm normalized name: CLOZAPINE (GOLDEN STATE)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Global ground-state potential energy surface (PES) for triplet O4 based on MS-CASPT2/maug-cc-pVTZ electronic structure calculations.
Trial: 19508580
Drug: Zinc oxide
RxNorm normalized name: Zinc Oxide
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zinc oxide cream
Trial: 24399554
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (varenicline and bupropion SR)
Trial: 24399554
Drug: Varenicline monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline monotherapy
Trial: 18343249
Drug: CH-1504 (1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CH-1504 (1, 5, 7.5, 10, 15, or 20 mg)
Trial: 18343249
Drug: CH-1504 (7.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CH-1504 (7.5, 10, or 15 mg)
Trial: 16005507
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group - fresh dentin with no surface treatment
Trial: 9030363
Drug: Control treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatments (other treatment arms)
Trial: 7967434
Drug: Erwinia L-asparaginase
RxNorm normalized name: Erwinia L-asparaginase
DrugBank: Asparaginase Erwinia chrysanthemi (DB08886)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erwinia L-asparaginase therapy
Trial: 7967434
Drug: Prophylactic use
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic use of anticoagulants (under investigation)
Trial: 11952670
Drug: Topical corticosteroid
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical corticosteroid applied twice daily starting from day 4
Trial: 11952670
Drug: Vehicle applied
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vehicle applied twice daily starting from day 4
Trial: 29660190
Drug: HBVaxPro©‐10 μg vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBVaxPro©‐10 μg vaccine
Trial: 27002062
Drug: Brivaracetam (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brivaracetam (150 mg single oral dose)
Trial: 27002062
Drug: Rifampin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin (600 mg/day for 5 days)
Trial: 24297971
Drug: Social networks
RxNorm normalized name: Safety 1st Social Safety Pack KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social networks intervention (peer support, monthly diabetes education sessions)
Trial: 20167142
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP), 88 micrograms, twice daily
Trial: 20167142
Drug: Montelukast, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast, 10 mg, daily
Trial: 18560254
Drug: Cognitive behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioural treatment and cognitive strategy training (8 group sessions each)
Trial: 12463081
Drug: Insoluble iodine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insoluble iodine skin preparation
Trial: 12463081
Drug: Other skin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other skin preparation methods
Trial: 7025883
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 (PGE2) vaginal pessaries (10 mg)
Trial: 7025883
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 (PGE2) vaginal pessaries (5 mg)
Trial: 28764579
Drug: Intravaginal dinoprostone
RxNorm normalized name: Dinoprostone
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravaginal dinoprostone tablet placement
Trial: 22024956
Drug: Creative arts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creative arts as a complementary therapy
Trial: 2865859
Drug: famotidine 40
RxNorm normalized name: famotidine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: famotidine 40 mg nocte
Trial: 2891224
Drug: famotidine 20
RxNorm normalized name: famotidine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: famotidine 20 mg bid
Trial: 2891224
Drug: famotidine 40
RxNorm normalized name: famotidine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: famotidine 40 mg bid
Trial: 28675812
Drug: Dexamethasone, 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone, 8 mg
Trial: 28675812
Drug: Diclofenac sodium,
RxNorm normalized name: diclofenac sodium, micronized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac sodium, 50 mg associated with codeine, 50 mg
Trial: 27447477
Drug: Oral diclofenac
RxNorm normalized name: diclofenac Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diclofenac (50 mg) before and after ERCP
Trial: 27447477
Drug: Oral diclofenac
RxNorm normalized name: diclofenac Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diclofenac (50 mg) in high-risk patients
Trial: 27447477
Drug: Oral diclofenac
RxNorm normalized name: diclofenac Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diclofenac (50 mg) in low-risk patients
Trial: 27447477
Drug: Oral diclofenac
RxNorm normalized name: diclofenac Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diclofenac (50 mg)
Trial: 20923960
Drug: Low intravenous
RxNorm normalized name: Dianeal Low Calcium 1.5 Intraperitoneal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low intravenous fat (32 g)
Trial: 20923960
Drug: High intravenous
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High intravenous fat (64 g)
Trial: 20923960
Drug: Low oral
RxNorm normalized name: Milkflow oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low oral fat (32 g)
Trial: 20923960
Drug: High oral
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High oral fat (64 g)
Trial: 12428181
Drug: Coenzyme Q10
RxNorm normalized name: Coenzyme Q10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coenzyme Q10 (CoQ) supplementation (100 mg twice daily for 12 weeks)
Trial: 12428181
Drug: Fenofibrate (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate (200 mg each morning for 12 weeks)
Trial: 22498212
Drug: Radiation plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation plus androgen deprivation therapy
Trial: 11803183
Drug: Clopidogrel (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (initial 300-mg loading dose, followed by 75-mg daily dose)
Trial: 2199290
Drug: Colchicine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine (1 mg orally every morning)
Trial: 400861
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg NA‐872 daily for 5 days
Trial: 400861
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg NA‐872 daily for 5 days
Trial: 7119300
Drug: Prednisone tablet
RxNorm normalized name: Prednisone Tablets
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone tablet
Trial: 25137188
Drug: Fluoxetine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine treatment over 12 weeks (8 sessions)
Trial: 15230343
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg disodium clodronate with 1% lidocaine
Trial: 15230343
Drug: Clody (same
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clody (same formulation without local anaesthetic)
Trial: 15230343
Drug: Clasteon (marketed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clasteon (marketed formulation containing 1% benzyl alcohol)
Trial: 7911813
Drug: Cabergoline (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabergoline (0.5 mg twice weekly)
Trial: 7911813
Drug: Quinagolide (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinagolide (75 micrograms once daily)
Trial: 26688732
Drug: Ciprofloxacin DPI
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin DPI 48.75 mg
Trial: 26688732
Drug: Placebo 32.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo 32.5 mg
Trial: 26688732
Drug: Placebo 48.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo 48.75 mg
Trial: 23576486
Drug: Cetuximab in
RxNorm normalized name: cetuximab Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil
Trial: 21041278
Drug: Atorvastatin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin therapy (40 mg/day) combined with methotrexate (MTX; 0.2 mg/kg/week) and prednisone (10 mg/day)
Trial: 21041278
Drug: Methotrexate (MTX;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrexate (MTX; 0.2 mg/kg/week) plus prednisone (10 mg/day)
Trial: 17219217
Drug: Alprazolam XR
RxNorm normalized name: ALPRAZOLAM 2 mg ORAL TABLET, EXTENDED RELEASE [Alprazolam XR]
DrugBank: Alprazolam (DB00404)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alprazolam XR (1 mg)
Trial: 17219217
Drug: Alprazolam IR
RxNorm normalized name: Alprazolam
DrugBank: Alprazolam (DB00404)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alprazolam IR (1 mg)
Trial: 11059965
Drug: Salmeterol added
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol added to low-dose inhaled corticosteroids (ICS)
Trial: 8872688
Drug: Midazolam 0.5
RxNorm normalized name: midazolam 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.5 mg/kg orally
Trial: 1623899
Drug: Metamizole 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metamizole 3 x 1 g for 3 days